BST02

Liver cancer (all types)

Phase 1Active

Key Facts

Indication
Liver cancer (all types)
Phase
Phase 1
Status
Active
Company

About Biosyngen

Biosyngen builds first‑in‑class cell‑therapy platforms to treat solid‑tumor cancers with rapid, safe, and scalable manufacturing.

View full company profile

Therapeutic Areas